探讨依维莫司联合他莫昔芬对激素受体阳性及HER2阴性转移性乳腺癌患者的作用

摘要

1文献来源Bachelot T,Bourgier C,Cropet C,et al.Randomized phase Ⅱ trial of Everolimus in combination with Tamoxifen in patients with hormone receptor-positive,human epidermal growth factor receptor2-negative metastatic breast cancer with prior exposure to aromatase inhibitors：A GINECO study[J].J Clin Oncol,2012,30（22）：2718-2724.2证据水平1b。